Episode
Gibraltar, vaccine failure
- Podcast
- Dr. John Campbell
- Published
- Sep 17, 2026
- Duration seconds
- 1896
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/VG2762395474.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/dr-john-campbell-7851784/episodes/gibraltar-vaccine-failure/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/dr-john-campbell-7851784/gibraltar-vaccine-failure.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Gibraltar Population, 33,691 Has administered at least 94,469 vaccine doses Enough to have fully vaccinated 140.2% of the country’s population. Face masks required in all shops and supermarkets, public transport, in medical centres, indoor funerals, Airport. https://www.worldometers.info/coronavirus/country/gibraltar/ Europe https://www.who.int/emergencies/diseases/novel-coronavirus-2019 World Health Organization Europe remains “in the firm grip” Death toll could top 2.2 million this winter Another 700,000 deaths by March 1 high or extreme stress in intensive care units (ICUs) in 49 out of 53 countries between now and March 1, 2022 Director for WHO Europe, Hans Kluge face a challenging winter ahead vaccine plus Face masks reduce COVID incidence by 53 % Over 160,000 deaths could be prevented (by March 1) if universal mask coverage of 95% Pascal Soriot, the chief executive of AstraZeneca https://www.telegraph.co.uk/news/2021/11/23/astrazeneca-jab-could-reason-britain-faring-better-europe-says/ UK not seeing so many hospitalisations relative to Europe despite a high number of cases. Long term T cell immunity after antibodies wane Looks like, AstraZeneca initially gives higher levels of T-cells France, Germany, Spain, Belgium – restricted AZ to the under 65s UK may have high T cells from natural infection and cross immunity from other coronavirus infections Government source European leaders had all these unfounded concerns about AstraZeneca and its use in older people If you look at the data, you can see us using it early has been incredibly helpful in terms of protecting older and vulnerable people from this disease for longer Dr Peter English People whose immune systems have produced a strong T-cell response but a weaker antibody response might be more likely to be infe…